Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Global Cord Blood Corporation Announces Termination of Discussion Regarding Cordlife Merger Proposal 2021-02-11 20:00
Acknowledged scientific leader and Novartis veteran joins Sai Life Sciences 2021-02-11 17:00
Firmenich Reports Solid Half Year Results despite Pandemic 2021-02-11 14:00
Zymo Research Launches COVID-19 Sequencing Service for the Detection and Surveillance of Emerging SARS-CoV-2 Variants 2021-02-11 13:46
Transcenta Holding Announces Appointment of Dr. Michael Shi as Executive Vice President, Head of Global R&D and Chief Medical Officer 2021-02-11 08:00
'Supercharger' to revive mainstay antibiotic in global fight against antibiotic resistance 2021-02-11 06:00
MGI's "Super Sequencer" Helps Sweden's National Pandemic Center Monitor COVID-19 Mutations 2021-02-10 18:52
Alterity Therapeutics announces funding from Michael J. Fox Foundation for ATH434 dose optimization for Parkinson's disease clinical trials 2021-02-09 21:53
Neurophth Closes RMB 400 Million Series B Financing 2021-02-09 21:44
Regent Pacific's Strategic Partner Obtains Clinical Trial Approval for FORTACIN(TM) 2021-02-09 20:35
Nuance Pharma Announces Strategic Licensing Deal with Antibe Therapeutics in China 2021-02-09 20:00
Experiment showed that Jemincare's neutralizing antibody JMB2002 would likely keep the potency against the South African mutant 2021-02-09 11:18
The World's Largest 36,000L Biomanufacturing Line Using Single-use Bioreactors Launches GMP Operation at WuXi Biologics 2021-02-09 08:25
Proxima Ventures and Co-win Ventures invest in Bioelectronica® Corporation to accelerate pharmaceutical discovery and development 2021-02-09 04:46
Longevity Acquisition Corporation Announces 4D pharma Clinical Trial Collaboration and Supply Agreement for the Treatment of Locally Advanced or Metastatic Urothelial Carcinoma 2021-02-08 21:00
Inova Appoints Claude Basset as Chief Product Officer 2021-02-08 16:00
Orpha Labs AG Initiates Compassionate Use Program for ORL-101 in Leukocyte Adhesion Deficiency Type II (LAD-II) 2021-02-08 15:00
I-Mab Announces Multiple Clinical Advancements of Its Differentiated CD73 Antibody Uliledlimab in China and the U.S. 2021-02-05 21:00
I-Mab Announces First Patient Dosed in Phase 2 Clinical Trial of TJ107 in Glioblastoma Multiforme in China 2021-02-04 21:00
Covid-19 Drug Duo Achievements: GoldenBiotech's New Drug Antroquinonol (HOCENA) Trial Receives Positive Response from DMC Review and Licenses for 4 Countries 2021-02-04 20:30
1 332 333 334 335 336 525